Impact of COVID-19 pandemic on the course of refractory chronic spontaneous urticaria under omalizumab treatment.
第一作者:
Müge,Olgaç
第一单位:
Division of Immunology and Allergic Diseases, Şişli Hamidiye Etfal Research and Education Hospital, Istanbul, Turkey. Electronic address: drmugeolgac@yahoo.com.tr.
作者:
主题词
人类(Humans);抗变态反应药(Anti-Allergic Agents);疾病大流行(Pandemics);治疗结果(Treatment Outcome);慢性病(Chronic Disease);荨麻疹(Urticaria)
DOI
10.1016/j.abd.2022.08.006
PMID
36609081
发布时间
2023-03-06
- 浏览0
Anais brasileiros de dermatologia
189-197页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文